Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Jianfeng Xu, Siqun Lilly Zheng, Sarah D. Isaacs, Kathleen E. Wiley, Fredrik Wiklund, Jielin Sun, A. Karim Kader, Ge Li, Lina D. Purcell, Seong Tae Kim, Fang Chi Hsu, Pär Stattin, Jonas Hugosson, Jan Adolfsson, Patrick C. Walsh, Jeffrey M. Trent, David Duggan, John Carpten, Henrik Grönberg, William B. Isaacs

Research output: Contribution to journalArticlepeer-review

92 Scopus citations


Autopsy studies suggest that most aging men will develop lesions that, if detected clinically, would be diagnosed as prostate cancer (PCa). Most of these cancers are indolent and remain localized; however, a subset of PCa is aggressive and accounts for more than 27,000 deaths in the United States annually. Identification of factors specifically associated with risk for more aggressive PCa is urgently needed to reduce overdiagnosis and overtreatment of this common disease. To search for such factors, we compared the frequencies of SNPs among PCa patients who were defined as having either more aggressive or less aggressive disease in four populations examined in the Genetic Markers of Susceptibility (CGEMS) study performed by the National Cancer Institute. SNPs showing possible associations with disease severity were further evaluated in an additional three independent study populations from the United States and Sweden. In total, we studied 4,829 and 12,205 patients with more and less aggressive disease, respectively. We found that the frequency of the TT genotype of SNP rs4054823 at 17p12 was consistently higher among patients with more aggressive compared with less aggressive disease in each of the seven populations studied, with an overall P value of 2.1 x 10-8 under a recessive model, exceeding the conservative genome-wide significance level. The difference in frequency was largest between patients with high-grade, non-organ-confined disease compared with those with low-grade, organ-confined disease. This study demonstrates that inherited variants predisposing to aggressive but not indolent PCa exist in the genome, and suggests that the clinical potential of such variants as potential early markers for risk of aggressive PCa should be evaluated.

Original languageEnglish (US)
Pages (from-to)2136-2140
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number5
StatePublished - Feb 2 2010


  • Association
  • Genetics
  • Gleason grade
  • SNP
  • Stage

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Inherited genetic variant predisposes to aggressive but not indolent prostate cancer'. Together they form a unique fingerprint.

Cite this